A study of the effect of an oral contraceptive on blood coagulation factors, platelets and fibrinolytic activity
- 30 April 1974
- journal article
- Published by Elsevier in Contraception
- Vol. 9 (4) , 379-392
- https://doi.org/10.1016/0010-7824(74)90081-x
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- EFFECT OF COMBINED ŒSTROGEN-PROGESTOGEN ORAL CONTRACEPTIVES, ŒSTROGEN, AND PROGESTOGEN ON ANTIPLASMIN AND ANTITHROMBIN ACTIVITYThe Lancet, 1970
- Progesterone oral contraception and blood coagulation.BMJ, 1969
- EFFECT OF $OElig;STRIOL ON PLATELET ADHESIVENESS AND FIBRINOLYSIS IN MENThe Lancet, 1966
- Clotting Factors during Oral Contraception: Further ReportBMJ, 1966
- ORAL CONTRACEPTION AND BLOOD-PLATELET ADHESIVENESSThe Lancet, 1965
- Thrombo‐Embolism in Patients with Total Proconvertin (Factor VII) DeficiencyActa Medica Scandinavica, 1962
- The Specific Assay of Prower-Stuart Factor and Factor VIIActa Haematologica, 1961
- Thrombosis and Factor VII ActivityJournal of Clinical Pathology, 1957
- The Assay of Antihaemophilic-Globulin ActivityBritish Journal of Haematology, 1955
- Über die Entstehungsbedingungen der Spontanen VenenthromboseJournal of Molecular Medicine, 1927